Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Stocks that pay dividends tend to outperform ones that don't. Consensus price targets for Novo Nordisk suggest the stock can ...

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

I was just a baby scientist when I discovered the hormone that made Ozempic possible. I had no idea how life-changing—and ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

In a June 24, 2025, podcast, Goldman Sachs’ Christian Mueller-Glissmann and Alexandra Wilson-Elizondo examined the dynamics ...

Multimodal AOMs were associated with the highest preoperative weight loss among patients with high BMI undergoing bariatric surgery.